Biote (BTMD) Capital Expenditures (2021 - 2026)

Biote (BTMD) has reported Capital Expenditures for 6 consecutive years, with $806000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Capital Expenditures fell 50.55% year-over-year to $806000.0; the TTM figure through Mar 2026 stood at $4.2 million (up 188.64% YoY), while the FY2025 annual figure was $5.0 million, up 853.42% from the prior year.
• Capital Expenditures came in at $806000.0 for Q1 2026 at Biote, down from $1.1 million in the prior quarter.
• The five-year high for Capital Expenditures was $1.8 million in Q4 2023, with the low at -$590000.0 in Q4 2024.
• Average Capital Expenditures over 5 years is $564625.0, with a median of $440500.0 recorded in 2023.
• Across the five-year window, Capital Expenditures surged 36620.0% in 2023 and plunged 1100.0% in 2024, its largest moves.
• Year by year, Capital Expenditures stood at $5000.0 in 2022, then soared by 36620.0% to $1.8 million in 2023, then plunged by 132.14% to -$590000.0 in 2024, then jumped by 282.54% to $1.1 million in 2025, then dropped by 25.16% to $806000.0 in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $806000.0, $1.1 million, and $499000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.